Receiving a diagnosis of breast cancer was one of the more traumatic moments I’ve experienced, but the way I found out added ...

In this Fall issue of CURE, we focus on AYAs with cancer, latest treatments in small cell lung cancer, preparing for a virtual visit and answering common questions about breast cancer.

Patients with non-small cell lung cancer saw a reduction in their risk of recurrence or death after surgery when treated with ...

Patients can benefit from clinical trials in gynecologic cancers, and knowing that they can advocate for themselves for ...

Dr. Debu Tripathy, editor-in-chief of CURE magazine, discusses the advancements made in small cell lung cancer.

Since my diagnosis with multiple myeloma, I try to keep inspired to keep moving forward despite the challenges.

A patient with metastatic breast cancer confronts financial toxicity and finds a little glimmer of hope through donating ...

With pivotal trial results and an approval from the FDA, the landscape is changing for patients with small cell lung cancer.

Surgery for gynecologic cancers is a common form of treatment, but each surgical approach has its advantages and ...

Researchers have compared Xtandi and Zytiga head-to-head in the treatment of metastatic castration-resistant prostate cancer.

Rybrevant plus Lazcluze, compared with Tagrisso, showed a trend towards favorable overall survival in EGFR-positive advanced ...

The recent FDA approval of Lazcluze plus Rybrevant for EGFR-mutant non-small cell lung cancer is a “big deal” for patients, ...